We are live on ! Find out more
SPRB

Spruce Biosciences

50 hedge funds and large institutions have $79M invested in Spruce Biosciences in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

16% more funds holding

Funds holding: 4350 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

33% less capital invested

Capital invested by funds: $118M → $79M (-$39.1M)

Holders
50
Holders Change
+7
Holders Change %
+16.28%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
13
Reduced
9
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TSS
26
Two Sigma Securities
New York
$128K +$114K +383 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$124K +$1.79K +6 +2%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$122K +$108K +364 New
Charles Schwab
29
Charles Schwab
California
$83K
State Board of Administration of Florida Retirement System
30
State Board of Administration of Florida Retirement System
Florida
$78K
PCM
31
Prelude Capital Management
New York
$75K +$66.4K +223 New
Squarepoint
32
Squarepoint
New York
$61K +$53.9K +181 New
Morgan Stanley
33
Morgan Stanley
New York
$55K -$252K -847 -84%
LCM
34
Laurion Capital Management
New York
$51K
Wells Fargo
35
Wells Fargo
California
$43K -$5.95K -20 -14%
Nuveen
36
Nuveen
North Carolina
$29K -$45.2K -152 -50%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$27K
Deutsche Bank
38
Deutsche Bank
Germany
$24K +$893 +3 +4%
UBS Group
39
UBS Group
Switzerland
$24K +$21.1K +71 New
TRCT
40
Tower Research Capital (TRC)
New York
$22K +$6.85K +23 +53%
AIG
41
American International Group
New York
$21K -$298 -1 -2%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$17K -$3.87K -13 -21%
Citigroup
43
Citigroup
New York
$10K +$3.27K +11 +61%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$8K +$3.57K +12 +100%
CAPTRUST Financial Advisors
45
CAPTRUST Financial Advisors
North Carolina
$7K +$5.95K +20 New
AIP
46
Ameritas Investment Partners
Nebraska
$3K
Legal & General Group
47
Legal & General Group
United Kingdom
$3K
EI
48
Ellevest Inc
New York
$1K +$595 +2 New
CAL
49
Capital Advisors Ltd
Ohio
$1K +$893 +3 New
TWA
50
TCI Wealth Advisors
Arizona
$1K +$893 +3 New

SPRB Hedge Fund Activity: Q4 2021 in Review

50 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q4 2021, worth a combined $79M — down 33% from $118M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new SPRB positions and 10 closed out — a net gain of 7 holders — while 13 added to existing stakes and 9 trimmed.

The largest buyer was Logos Global Management, opening a new position worth an estimated $4.37M. The largest seller was Deerfield Management, exiting entirely with an estimated $13.2M sold.

  • 50 institutional investors held Spruce Biosciences (SPRB) as of Q4 2021, up from 43 in Q3 2021.
  • Funds reported $79M of Spruce Biosciences stock for Q4 2021, down 33% quarter-over-quarter.
  • 17 funds opened new Spruce Biosciences positions in Q4 2021 and 10 closed out, a net change of +7 holders.
  • The largest Spruce Biosciences buyer in Q4 2021 was Logos Global Management, an estimated $4.37M added.
  • The largest Spruce Biosciences seller in Q4 2021 was Deerfield Management, an estimated $13.2M sold.

Based on aggregated 13F filings for Q4 2021.